XHKG
1084
Market cap70mUSD
Oct 09, Last price
0.64HKD
1D
0.00%
1Q
-12.33%
IPO
-47.11%
Name
Green Future Food Hydrocolloid Marine Science Co Ltd
Chart & performance
P/E
84.32
P/S
0.61
EPS
0.01
Div yield, %
1.88%
Shrs. gr., 5y
0.99%
Rev. gr., 5y
0.61%
Revenues
904m
-8.53%
Net income
7m
-89.40%
CFO
-20m
L
Dividend
Jun 16, 20260.012 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Green Fresh Biotechnology Co., Ltd. operates as an investment holding entity with its core business focused on the manufacturing and distribution of hydrocolloid products for the food industry. The company's activities are organized across distinct product lines: Agar-Agar, Carrageenan, Konjac Products, and a range of Blended Products. This firm was established on July 3, 2015, and its main office is situated in Hong Kong.
Key people
Shui Yip Chan
Executive Vice Chairman of the Board, Vice President
Dongxu Guo
Executive Vice Chairman of the Board, Vice President
Kam Chung Chan
Executive Chairman of the Board, Chief Executive Officer
Yi Chen
Executive Director · since 2024
Xiaoying She
Executive Director
Chi Man So
Company Secretary
Kwai Ching Ho
Non-Executive Independent Director
Non-Executive Independent Director
Non-Executive Independent Director
IPO date
Oct 17, 2019
Employees
1,234
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||